Entopharm Co., Ltd.
Records under this name other than patents Entopharm Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 3 of 3 · Back to Entopharm Co., Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,462,360 | Alloferons—immunomodulatory peptides Formerly held Term ended Term ended Jul 13, 2022 · From the USPTO record | Term ended | Term ended Jul 13, 2022 | From the USPTO record |
| US 6,692,747 | Alloferons—immunomodulatory peptides Formerly held Term ended Term ended Dec 27, 2020 · From the USPTO record | Term ended | Term ended Dec 27, 2020 | From the USPTO record |
| US 6,337,093 | Immunomodulatory and antimicrobial materials, their preparation and use Formerly held Term ended Term ended Dec 2, 2019 · From the USPTO record | Term ended | Term ended Dec 2, 2019 | From the USPTO record |